Would-be biotech investors remind me of meme coin traders in the trenches. Most biotechs are overvalued shitters with massive debt, high risk of dilution and small or irrelevant pipelines. A lot of friends have DM'ed me hot name biotechs that have broken out recently...but 9/10 are genuine garbage. A couple things to keep in mind : -nonservicable debt and dilution are not acceptable -just bc a drug is approved or likely to be approved doesnt mean its a blockbuster (or going to be) ...for example:no one cares about the 6th generation PPI or another immunologic for hydradentitis -more than any other type sector, biotechs are prone to buy the run up to approval/sell the news bc it takes 12-24m minimum to properly scale and commercialize new drugs Id caution you to be mindful of fundamentals or someday you're going to find yourself in the same situation as a turkey on Thanksgiving.(CryptoCondom)